Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

NCT04337970

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Completed

Pembrolizumab (MK-3475) as First-line Therapy for Advanced Merkel Cell Carcinoma (MK-3475-913)

NCT03783078

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Merkel Cell, +15 more
Locations
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone Health ( Site 0006) New York, United States
  • Icahn School of Medicine at Mount Sinai ( Site 0004) New York, United States
  • Melanoma Institute Australia ( Site 0400) North Sydney, New South Wales, Australia
  • Calvary Mater Newcastle ( Site 0402) Waratah, New South Wales, Australia
View all 22 locations
View Trial Details
Completed

A Study of IMM-6-415 in RAS/RAF Mutant Solid Tumors

NCT06208124

Conditions
Adenocarcinoma, Advanced Solid Tumor (Phase 1), Bronchial Neoplasms, +25 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • City of Hope Duarte, California, United States
  • Sarah Cannon Research Institute Denver, Colorado, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Rucaparib in Treating Patients With Genomic LOH High and/or Deleterious BRCA1/2 Mutation Stage IV or Recurrent Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

NCT03845296

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +23 more
Locations
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 950 locations
View Trial Details

Related conditions